Editorial Commentary : Machine Learning and 300,000 Simulations Confirm That Fragility Reflects the P Value, Not Trial Robustness: Taking Apart a Calculator to Reveal That 2 +

Abstract

The fragility index continues to be promoted as a measure of trial robustness despite evidence that it is little more than statistical significance in a different form. Two misconceptions have been particularly persistent throughout the fragility literature: first, that the fragility index can be directly compared with patients lost to follow‐up, and second, that fragility metrics provide unique insight into the robustness of randomized controlled trials. Both assumptions are flawed. Outcome reversals used to calculate the fragility index and the addition of patients lost to follow‐up are fundamentally different mathematical operations and therefore should not be expected to have equivalent effects on statistical significance. Likewise, because fragility metrics are deterministic functions of variables already used to calculate the P value, it should not be surprising when statistical models identify P values, event counts, and sample size as their dominant determinants. In many ways, using machine learning to identify the factors that drive fragility metrics is analogous to taking apart a calculator to determine why 2 + 2 equals 4: the answer is technically correct but largely predetermined by the construction of the system itself. The more important question is not what determines fragility but whether fragility contributes meaningful information beyond conventional statistical outputs. If fragility metrics can be reconstructed almost entirely from variables already reported in every randomized controlled trial, then their incremental value becomes difficult to justify. After nearly a decade of fragility analyses reaching the same conclusions, it may be time to move beyond fragility metrics altogether and refocus on approaches that directly address uncertainty, bias, precision, and clinical relevance. Confidence intervals, risk of bias assessments, reproducibility, and thoughtful interpretation of effect estimates provide far greater insight into study credibility than another measure derived largely from the P value. It is time to move past fragility and return our attention to the factors that actually determine robustness.